REQUEST A DEMO
Total
USD $0.00
Search more companies

Read-Gene S.A. (Poland)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Medical and Diagnostic Laboratories
Full name: Read-Gene S.A. Profile Updated: October 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Read-Gene S.A. is a company located in Szczecin, Poland. The company specializes in chemoprevention, clinical research, and genetic testing. These segments of the company's business are complementary to each other. Chemoprevention involves the use of natural or synthetic substances to inhibit, reverse, or delay the process of developing cancer. Clinical research focuses on determining the effectiveness, safety, and achievement of basic goals of potential drugs, preparations, or medical technologies. READ-GENE offers its services in these areas to corporate clients, primarily in the medical, pharmaceutical, chemical, and biotechnological industries.

Headquarters
ul. Akacjowa 2
Szczecin; Zachodniopomorskie; Postal Code: 71-253

Contact Details: Purchase the Read-Gene S.A. report to view the information.

Website: http://www.read-gene.com

Basic Information
Total Employees:
Purchase the Read-Gene S.A. report to view the information.
Outstanding Shares:
Purchase the Read-Gene S.A. report to view the information.
Registered Capital:
Purchase the Read-Gene S.A. report to view the information.
Financial Auditors:
Purchase the Read-Gene S.A. report to view the information.
Incorporation Date:
September 27, 2005
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Ownership Details
Purchase this report to view the information.
67.06%
Purchase this report to view the information.
7.16%
Purchase this report to view the information.
5.94%
Subsidiaries
Dieta Antyrakowa Read- Gene Sp. z o.o.
100%
Innowacyjna Medycyna Sp. z o.o.
100%
Company Performance
Financial values in the chart are available after Read-Gene S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
40.13%
Total operating revenue
40.15%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total assets
-3.3%
Total equity
-24.44%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
52.21%
Quick Ratio
-6.71%
Cash Ratio
-7.37%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?